» Authors » Takahito Nakama

Takahito Nakama

Explore the profile of Takahito Nakama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 560
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukuda Y, Ishikawa K, Kiyohara K, Maehara Y, Ji R, Mori K, et al.
Transl Vis Sci Technol . 2024 Aug; 13(8):13. PMID: 39115838
Purpose: Proliferative retinal changes may occur postsurgery for rhegmatogenous retinal detachment (RRD), possibly preceding recurrent detachment. This study aims to establish the groundwork for an imaging system capable of discerning...
2.
Nagata J, Shiose S, Ishikawa K, Fukui T, Kano K, Mori K, et al.
J Clin Med . 2023 Sep; 12(17). PMID: 37685562
Background: Although anti-vascular endothelial growth factor (anti-VEGF) therapy is the first choice of treatment for eyes with neovascular age-related macular degeneration (AMD), it sometimes results in retinal pigment epithelium (RPE)...
3.
Yamaguchi M, Nakao S, Wada I, Matoba T, Arima M, Kaizu Y, et al.
Diabetes . 2022 Oct; 71(12):2685-2701. PMID: 36203331
Intraretinal hyperreflective foci (HRF) are significant biomarkers for diabetic macular edema. However, HRF at the vitreoretinal interface (VRI) have not been examined in diabetic retinopathy (DR). A prospective observational clinical...
4.
Ishikawa K, Akiyama M, Mori K, Nakama T, Notomi S, Nakao S, et al.
Am J Ophthalmol . 2021 Aug; 234:20-27. PMID: 34339662
Purpose: To describe the factors associated with epiretinal membrane (ERM) formation in eyes treated with pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD). Design: Nationwide, multicenter, clinical cohort study...
5.
Mori Y, Arima M, Ueda E, Fujiwara K, Seki E, Nakama T, et al.
Eye (Lond) . 2020 Dec; 35(10):2820-2825. PMID: 33257802
Background/objectives: The prevalence of myopia is higher in preterm infants who underwent laser photocoagulation (LPC) for retinopathy of prematurity (ROP). The aim of this study was to investigate factors associated...
6.
Mori K, Ishikawa K, Wada I, Kubo Y, Kobayashi Y, Nakama T, et al.
PLoS One . 2020 Oct; 15(10):e0241343. PMID: 33112920
This study aims to investigate the changes in metamorphopsia after administering the treat-and-extend regimen of anti-vascular endothelial growth factor therapy for branch retinal vein occlusion-associated macular edema. We retrospectively examined...
7.
Kubo Y, Ishikawa K, Mori K, Kobayashi Y, Nakama T, Arima M, et al.
Sci Rep . 2020 Jun; 10(1):9299. PMID: 32518264
Ischemic proliferative retinopathy (IPR), such as proliferative diabetic retinopathy (PDR), retinal vein occlusion and retinopathy of prematurity is a major cause of vision loss. Our previous studies demonstrated that periostin...
8.
Arima M, Akiyama M, Fujiwara K, Mori Y, Inoue H, Seki E, et al.
PLoS One . 2020 Mar; 15(3):e0230678. PMID: 32196539
Purpose: The purpose of this study was to evaluate neurodevelopmental outcomes in 18-month old (corrected age) preterm infants who received an intravitreal bevacizumab (IVB) injection for the treatment of type...
9.
Peng Y, Cao M, Yoshida S, Zhang L, Zeng H, Zou J, et al.
Int J Ophthalmol . 2019 Feb; 12(2):212-218. PMID: 30809475
Aim: To investigate the regulation and mechanisms of periostin expression in retinal Müller glia, and to explore the relevance to retinal neovascularization. Methods: The oxygen-induced retinopathy (OIR) mouse model and...
10.
Sasaki F, Koga T, Ohba M, Saeki K, Okuno T, Ishikawa K, et al.
JCI Insight . 2018 Sep; 3(18). PMID: 30232269
Age-related macular degeneration (AMD), a progressive chronic disease of the central retina, is associated with aging and is a leading cause of blindness worldwide. Here, we demonstrate that leukotriene B4...